• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2018; 42(3) e37-e39

Pubblicato on-line:

May 25, 2018

DOI:

10.19186/BC_2018.032

Scarica in PDF:
Autenticazione richiesta

Ruolo del laboratorio nella valutazione di un donatore di organi con sospetta emofilia A

AUTORI

Eva Milletti1,2, Claudia Bellini1,2, Francesca Cinci1,2, Eleonora Franceschini1, Daniela Fineschi1, Roberto Guerranti1,2, Antonella Silvietti1, Daniela Vannoni1,2, Lucia Terzuoli1,2, Roberto Leoncini1,2, Carlo Scapellato1, Giovanbattista Ippoliti3, Paola Calzoni1
1UOC Laboratorio Patologia Clinica, Azienda Ospedaliera Universitaria Senese, Policlinico Santa Maria alle Scotte, Siena
2Dipartimento di Biotecnologie Mediche, Università di Siena
3Dipartimento di Medicina Interna, Policlinico di Monza

ABSTRACT

Role of the laboratory in the evaluation of an organ donor with reported haemophilia A

The case concerns a 82-year-old patient, organ donor, affected by diabetes mellitus, hypertension and reported type A haemophilia, showing a traumatic severe cerebral haemorrhage. The Medical Committee started the donor evaluation process: the liver was compatible for a recipient in life-threatening conditions. Although the first level coagulation tests were within the normal range, the Regional Center for Organ and Tissue Allocation of the Tuscany Region – Italy requested further investigations in order to clarify the reported diagnosis of haemophilia and to exclude the presence of a specific FVIII inhibitor. FVII activity was evaluated to assess the protein synthesis of the liver, and FVIII for suspected haemophilia; both of them were normal. Considering the importance of the diagnosis, the parallelisms of both FVII and FVIII were performed; the tests were negative for the presence of inhibitors. Second-level tests therefore rejected the diagnosis of haemophilia and excluded the presence of a specific inhibitor of FVIII. The absence of coagulative alterations allowed the liver explant, which was successfully transplanted on a 59-year-old male recipient.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967